Source: Global Corporate Venturing

Anaeropharma: Anaeropharma adds Novartis to its investors

Novartis has joined Shinsei Corporate Investment, Seventure Partners, INCJ and Mitsubishi UFJ Capital in a $13.2m round for the cancer drug developer.

Read full article »
Anaeropharma's Competitors | Anaeropharma's News | Anaeropharma's Financials
Stay up-to-date with the latest news on Anaeropharma Science
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Tetsuya Mishima's photo - President & CEO of Anaeropharma Science

President & CEO

Tetsuya Mishima

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on Anaeropharma Science